Answers are grounded in this paper and cite their sources.
BACKGROUND: To descriptively compare genomic profiles by human papillomavirus (HPV) status in a Taiwanese multicenter registry with published Western cohorts. METHODS: We reviewed aggregate findings from 290 OPSCC cases in TCOG T1322 (ACTOnco + 440-gene panel) and selected studies from the United States and Europe. No formal cross-cohort statistical comparison was performed. RESULTS AND DISCUSSION: Major driver-gene patterns were broadly similar across cohorts. In the T1322 TMB-evaluable subset (HPV-positive n = 187; HPV-negative n = 99), the supplied summary reported a median TMB of 3.2 mutations/Mb in both groups, with interquartile ranges of 1.3-5.7 and 1.9-4.4 mutations/Mb, respectively. A verified p value for this updated subset was unavailable; therefore, no inference about statistical significance is made. CONCLUSION: Cross-study patterns are hypothesis-generating, and quantitative biomarker comparisons require harmonized methodology and independent validation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: